Company Overview

Development Stage

About the Company

[Summary] Top 100 Chinese Pharmaceutical Industry Enterprises

Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. is a large pharmaceutical enterprise group integrating drug research and development, production, trade, and medical and health services. Since 2006, it has been consecutively listed among the Top 100 Chinese Pharmaceutical Industry Enterprises, and since 2011, it has been rated as the Best Enterprise for Pharmaceutical R&D Product Lines in China. It is a national key high-tech enterprise, a national technology innovation demonstration enterprise, a national quality benchmark enterprise, and a national intellectual property demonstration enterprise, and has been rated by China Pharmaceutical Economic News as one of China's top ten pharmaceutical enterprises with the strongest growth potential. The Group consistently adheres to the strategic policy of "prospering the enterprise through science and technology," having established a research center within Shanghai Zhangjiang Hi-Tech Park, which undertakes the research and development of high-tech projects and the cultivation of high-tech talent. Together with the headquarters, it forms a comprehensive research system that vigorously drives the development of new drugs. Currently, the company is actively expanding innovative research and development, comprehensively advancing the consistency evaluation of generic drugs, thereby laying a solid foundation and momentum for enterprise development. The company has multiple production bases for chemical drugs (API and formulations) and traditional Chinese medicine, boasting over seventy production lines including powder injections, lyophilized powder injections, solid preparations, large and small volume injections, chemical APIs, cephalosporin APIs, and traditional Chinese medicine, with more than 300 product specifications launched on the market. The company is accelerating the expansion of domestic and international sales of specialty APIs, seizing the opportunities of global generic drug growth and cross-border production transfer, to build a high-end, large-scale base for API production, export, and trade. Luoxin Group always upholds the values of "rewarding employees, rewarding customers, rewarding shareholders, rewarding society, and strengthening the enterprise," and sincerely invites you to join us, move forward hand in hand, deliver health, and create brilliance together!

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

How Fast Is Hiring Growing? (8 open positions)

Manage
Note: How fast is hiring at Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. growing? 2025: 106 openings (down 73%), 2024: 391 openings (up 11%), 2023: 353 openings (up 635%), 2022: 48 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Up 100%
  • 2024: Up 400%
Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. growing? Master's recruitment over the years: 2025: 10 openings (up 100%), 2024: 5 openings (up 400%), 2023: 1 openings.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.? Based on an analysis of 's job postings over the past year, "医疗卫生/美容保健类" demand: 21.4%, "生物/制药/化工/环保类": 14.3%, "其他(研发和技术类)": 11.9%, "计算机/网络/技术类": 8.3%, "科研类": 3.6%, "机械/仪器仪表类": 1.2%. For reference only.

— What Are the Salaries Like? (84 records)

Manage
salary range: 4.5K - 50K, 54.7% of roles pay ¥6-15K
Note: salary statistics are based on 84 salary records from the past year and depend on the job sample. For reference only.
How is the salary at Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.?54.7% of positions earn 6-15K, Undergraduate salary: ¥。Linyi salary ranking top 15,销售类 average salary ¥7.7K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at Shandong Luoxin Pharmaceutical Group Stock Co., Ltd.? We provide: 医药代表,药工,采购,化学,学工,工艺研发,技术负责,组长,车间,运营,销售,制剂研究,法务,研究员,融资,临床,优化总监,会计,出纳,工艺技术. Click to view detailed salary analysis by job.

This company — Fortune 500? (More)

Related Industry Tags

Job Category

  • 销售类
    35.7% of total 35.7%
  • 经营管理类
    34.5% of total 34.5%
  • 技工类
    23.8% of total 23.8%
  • 医疗卫生/美容保健类
    21.4% of total 21.4%

Education

  • 本科
    44% of total 44%
  • 硕士
    17.9% of total 17.9%
  • 高中
    13.1% of total 13.1%
  • 大专
    11.9% of total 11.9%

Experience

  • 1-3年
    35.7% of total 35.7%
  • 5-10年
    26.2% of total 26.2%
  • 不限
    21.4% of total 21.4%
  • 3-5年
    16.7% of total 16.7%
View Detailed Analysis

What does Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. require? Who is Shandong Luoxin Pharmaceutical Group Stock Co., Ltd. hiring? recruitment: 销售类占比最多占35.7%,其次是经营管理类占34.5%. What education can get in at ? 本科占比最多占44%,其次是硕士占17.9%. High education required at ? 硕士占17.9%. Work experience required at ? 1-3年占比最多占35.7%,其次是5-10年占26.2%. Where are the job locations at ? 临沂占比最多占60.7%,其次是邯郸占4.8%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 6,096万(元)
Legal Representative: 刘振腾
Date Established:
Credit Code: 913700002658705037
Registered Address: 山东省临沂高新技术产业开发区罗七路

Partners & Suppliers

国药控股黑龙江有限公司向罗欣药业采购消化系统、抗感染类药品 Source
合作客户 医药制造-化学药
获得罗欣药业替戈拉生片在中国大陆独家商业化权利 Source
合作客户 药品授权许可
经销商,采购罗欣药业药品 Source
合作客户 医药商业
经销商,采购罗欣药业药品 Source
合作客户 医药商业
经销商,采购罗欣药业药品 Source
合作客户 医药商业

People who follow this company also follow

Competitors (Similar Companies)

“Construction machinery equipment manufacturer”
制药/药业 盐酸 硝酸 奥美拉唑
制冷 生产 制造 研发
“Top 500 Chinese Enterprises”
生物制品 原料药 生物制药 胰岛素
医药分销 医药流通 大健康 物流分销
水溶肥 缓控释肥 化工/化学 控释肥
能源 燃气 储能 分布式能源
钢铁 金属材料 钢铁冶炼 冶炼
维生素 山梨酸 循环经济 山梨酸钾
制药/药业 医药 中成药 抗肿瘤药
焦炭 煤焦化 合成氨 甲醇
医药工业 医药
“Adhering to the corporate culture of science and excellence, committed”
连接器 充电枪 智能电网 矩形连接器

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates